Cited by 1,026Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

Maury, E., Brichard, S.M.·2010·Molecular and Cellular Endocrinology

Abstract

Obesity plays a causative role in the pathogenesis of the metabolic syndrome. Adipokines may link obesity to its co-morbidities. Most adipokines with pro-inflammatory properties are overproduced with increasing adiposity, while some adipokines with anti-inflammatory or insulin-sensitizing properties, like adiponectin are decreased. This dysregulation of adipokine production may promote obesity-linked metabolic disorders and cardiovascular disease. Besides considering adipokines, this review will also highlight the cellular key players and molecular mechanisms involved in adipose inflammation. Targeting the changes in the cellular composition of adipose tissue, the underlying molecular mechanisms, and the altered production of adipokines may have therapeutic potential in the management of the metabolic syndrome.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2009.07.031

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maury, E., & Brichard, S. M.
Affiliations
UCLouvain (BE)
Corresponding author
Brichard, S.M.
Venue
Molecular and Cellular Endocrinology
Publisher
Elsevier BV
Published
2010-01-15
Volume
314
Issue
1
Pages
1-16
ISSN
0303-7207 (ISSN-L)
OpenAlex
W2094498915
Cited by
1,026
References
230
Citations by year
2026: 20 · 2025: 33 · 2024: 40 · 2023: 38 · 2022: 44 · 2021: 64 · 2020: 69 · 2019: 71 · 2018: 51 · 2017: 61 · 2016: 70 · 2015: 93 · 2014: 73 · 2013: 97 · 2012: 85
FWCI
44.31
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular and Cellular Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
adipokines, adipose tissue inflammation, metabolic syndrome, obesity, adiponectin, insulin sensitivity, adipose tissue composition, cardiovascular disease, adipokine dysregulation, therapeutic target
MeSH terms
Apelin, Adipose Tissue, Humans, Inflammation, Insulin, Macrophages, Obesity, Tumor Necrosis Factor-alpha, Signal Transduction, Cytokines, Adipocytes, Chemokines, Metabolic Syndrome, Intercellular Signaling Peptides and Proteins, Body Fat Distribution, Adiponectin, Adipokines, Nicotinamide Phosphoribosyltransferase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review